Isaacs JT - Search Results

1

Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer.

Singh P, Hallur G, Anchoori RK, Bakare O, Kageyama Y, Khan SR, Isaacs JT. Singh P, et al. Among authors: isaacs jt. Prostate. 2008 Oct 1;68(14):1570-81. doi: 10.1002/pros.20821. Prostate. 2008. PMID: 18668523 Free PMC article.

2

Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657.

Lamb JC, Levy MA, Johnson RK, Isaacs JT. Lamb JC, et al. Among authors: isaacs jt. Prostate. 1992;21(1):15-34. doi: 10.1002/pros.2990210103. Prostate. 1992. PMID: 1641369

3

Epidemiologic evidence regarding predisposing factors to prostate cancer.

Carter BS, Carter HB, Isaacs JT. Carter BS, et al. Among authors: isaacs jt. Prostate. 1990;16(3):187-97. doi: 10.1002/pros.2990160302. Prostate. 1990. PMID: 1691839 Review.

4

Evaluation of Win 49,596, a novel steroidal androgen receptor antagonist, in animal models of prostate cancer.

Juniewicz PE, Fetrow N, Marinelli J, Wolf M, Young E, Lamb J, Isaacs JT. Juniewicz PE, et al. Among authors: isaacs jt. Prostate. 1991;18(2):105-15. doi: 10.1002/pros.2990180203. Prostate. 1991. PMID: 2006117

5

H-ras expression, genetic instability, and acquisition of metastatic ability by rat prostatic cancer cells following v-H-ras oncogene transfection.

Ichikawa T, Schalken JA, Ichikawa Y, Steinberg GD, Isaacs JT. Ichikawa T, et al. Among authors: isaacs jt. Prostate. 1991;18(2):163-72. doi: 10.1002/pros.2990180209. Prostate. 1991. PMID: 2006121

6

Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancers.

Vukanovic J, Hartley-Asp B, Isaacs JT. Vukanovic J, et al. Among authors: isaacs jt. Prostate. 1995 May;26(5):235-46. doi: 10.1002/pros.2990260503. Prostate. 1995. PMID: 7538663

7

Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells.

Rinker-Schaeffer CW, Partin AW, Isaacs WB, Coffey DS, Isaacs JT. Rinker-Schaeffer CW, et al. Among authors: isaacs wb, isaacs jt. Prostate. 1994 Nov;25(5):249-65. doi: 10.1002/pros.2990250505. Prostate. 1994. PMID: 7971516 Review.

8

Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer.

Denmeade SR, Lin XS, Isaacs JT. Denmeade SR, et al. Among authors: isaacs jt. Prostate. 1996 Apr;28(4):251-65. doi: 10.1002/(SICI)1097-0045(199604)28:4<251::AID-PROS6>3.0.CO;2-G. Prostate. 1996. PMID: 8602401 Review.

9

Development of a high-efficiency method for gene marking of Dunning prostate cancer cell lines with the enzyme beta-galactosidase.

Rinker-Schaeffer CW, Wharam JF, Simons J, Isaacs JT. Rinker-Schaeffer CW, et al. Among authors: isaacs jt. Prostate. 1996 Jul;29(1):60-4. doi: 10.1002/(SICI)1097-0045(199607)29:1<60::AID-PROS9>3.0.CO;2-M. Prostate. 1996. PMID: 8685057

10

The antiangiogenic agent linomide inhibits tumor necrosis factor-alpha secretion via inhibition of its synthesis.

Joseph IB, Isaacs JT. Joseph IB, et al. Among authors: isaacs jt. Prostate. 1996 Sep;29(3):183-90. doi: 10.1002/(SICI)1097-0045(199609)29:3<183::AID-PROS4>3.0.CO;2-F. Prostate. 1996. PMID: 8827087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters